Willian Setubal dos Santos

Willian Setubal dos Santos

Auto-generated profile, based on publicly available information

Willian Setubal dos Santos

Universidade Federal de São Paulo (Unifesp), Brazil

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Sao Paulo Medical Journal
Verified
Journal Article
Open access
WSWillian Setubal dos Santos
Willian Setubal dos Santos
OCOmar Carrión-Torres
Omar Carrión-Torres
MBMatheus Valadares Bertolini
Matheus Valadares Bertolini
VBVinicius Santos Baptista
Vinicius Santos Baptista
SYSamira Yarak
Samira Yarak
BACKGROUND: Delirium is a common and serious complication among elderly patients in intensive care units (ICUs), and is often associated with increased morbidity and mortality rates. The choice of sedoanalgesic may influence the incidence of delirium; however, the evidence remains unclear, particularly in the elderly population. OBJECTIVES: To evaluate the association between the use of different sedoanalgesics and the incidence of delirium in elderly ICU patients, based on data from randomized clinical trials. DESIGN AND SETTING: This systematic review was conducted using data from randomized clinical trials performed in various ICU settings. METHODS: A systematic search of the MEDLINE, Embase, and CENTRAL databases was performed in January 2024. The review included randomized clinical trials involving patients aged 60 years or older that examined the relationship between sedoanalgesics (midazolam, fentanyl, propofol, ketamine, and dexmedetomidine) and delirium incidence. Studies involving COVID-19 patients and non-randomized studies were excluded. RESULTS: A total of 1,331 patients from six studies were included. The mean age of the patients ranged from 71 to 74.7 years. Four studies compared dexmedetomidine with propofol; two found no significant difference in delirium incidence, whereas two suggested a lower incidence with dexmedetomidine. The remaining studies compared propofol with ketamine and dexmedetomidine with midazolam and showed no significant differences in the incidence of delirium. CONCLUSIONS: Dexmedetomidine may be associated with a lower incidence of delirium than propofol or midazolam in elderly ICU patients. However, further research is needed to confirm these findings and explore the factors contributing to delirium in this population. SYSTEMATIC REVIEW REGISTRATION: Registered with PROSPERO, CRD42024575693, available at https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=575693.